Ignite Creation Date:
2024-05-06 @ 2:47 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04422912
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2020-06-02
Brief Title:
A Phase 12 Open-label Safety and Dosing Study of Autologous CART Cells Desmoglein 3 Chimeric Autoantibody Receptor T Cells DSG3-CAART or CD19-specific Chimeric Antigen Receptor T Cells CABA-201 in Subjects With Active Pemphigus Vulgaris RESET-PV
Sponsor:
Cabaletta Bio
Organization:
Cabaletta Bio
Organization Data
Organization:
Cabaletta Bio
Class:
INDUSTRY
Study ID:
CAB-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cabaletta Bio
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None